Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

NCT05009082 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

970

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Bevacizumab
DRUG: Niraparib

Sponsor

AGO Study Group

Collaborators

[object Object]